Atorvastatin Calcium Hydrate/Candesartan Cilexetil

阿托伐他汀钙水合物/坎地沙坦西酯

Report date: 2024/09/20 20:00:41
NME

Base Information

Drug NameAtorvastatin Calcium Hydrate/Candesartan Cilexetil
Drug Alias NameAG1502AG-1502
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHMG-CoA reductase inhibitorsAngiotensin II Receptor Type 1 antagonists
TargetsHMG-CoA reductaseAngiotensin II Receptor Type 1
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAhn-Gook Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A